Lavina Talukdar | Head of Investor Relations |
Stéphane Bancel | Chief Executive Officer |
David Meline | Chief Financial Officer |
Stephen Hoge | President |
Corinne Le Goff | Chief Commercial Officer |
Jackie Miller | Senior Vice President, Therapeutic Head of Infectious Diseases |
Salveen Richter | Goldman Sachs |
Matthew Harrison | Morgan Stanley |
Ted Tenthoff | Piper Sandler |
Michael Yee | Jefferies |
Gena Wang | Barclays |
Good morning, and welcome to Moderna's Second Quarter earnings call. At this time, all participants are in listen-only-mode.
Following the formal remarks, we will open the call up for your questions. Please be advised, that the call is being recorded. At this time, I would like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna.